Portfolio company
Unlocked Labs
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops enzyme-rich postbiotic medical foods to target compounds driving chronic health conditions for patients with kidney stones or high cholesterol.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
BEO Therapeutics
This company develops oral microbiome therapies to treat patients with gouty arthritis and chronic kidney disease by reducing metabolic waste products.
Una Health
This company develops personalized digital therapy software and biosensor technology for individuals with type 2 diabetes to manage and reverse metabolic dysfunction.
Phenotap
This company develops enzymes for blood glucose and ketone monitoring device manufacturers to enable continuous metabolic tracking and diabetic ketoacidosis detection.
AminoSense
This company develops a biosensor platform for real-time amino acid measurement at home to help consumers optimize protein nutrition and metabolic health.
Chrysea Labs
The company develops precision nutritional supplements and interventions designed to promote healthy ageing and manage chronic conditions for health-conscious consumers.
GlycoX
This company develops a plant-based food ingredient designed to provide blood-sugar control and support metabolic health for health-conscious consumers.
Unravel Health
This company develops a palm-sized device for monitoring multiple hormones from saliva samples at home for women and clinical research partners.
Metabolize
This company develops dietary supplements for individuals managing weight after discontinuing or cycling off GLP-1 medications to help maintain muscle and regulate appetite.
